These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 26797656)
41. Usefulness of ketogenic diet in a girl with migrating partial seizures in infancy. Mori T; Imai K; Oboshi T; Fujiwara Y; Takeshita S; Saitsu H; Matsumoto N; Takahashi Y; Inoue Y Brain Dev; 2016 Jun; 38(6):601-4. PubMed ID: 26785903 [TBL] [Abstract][Full Text] [Related]
42. Wolf-Hirschhorn syndrome: a case study and disease overview. Bailey R Adv Neonatal Care; 2014 Oct; 14(5):318-21. PubMed ID: 25137600 [TBL] [Abstract][Full Text] [Related]
43. Duplication of the Wolf-Hirschhorn syndrome critical region causes neurodevelopmental delay. Hannes F; Drozniewska M; Vermeesch JR; Haus O Eur J Med Genet; 2010; 53(3):136-40. PubMed ID: 20197130 [TBL] [Abstract][Full Text] [Related]
44. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy. Dewey CW; Cerda-Gonzalez S; Levine JM; Badgley BL; Ducoté JM; Silver GM; Cooper JJ; Packer RA; Lavely JA J Am Vet Med Assoc; 2009 Dec; 235(12):1442-9. PubMed ID: 20001779 [TBL] [Abstract][Full Text] [Related]
45. A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant. El Halabi T; Dirani M; Hotait M; Nasreddine W; Beydoun A Epilepsia Open; 2021 Mar; 6(1):73-78. PubMed ID: 33681650 [TBL] [Abstract][Full Text] [Related]
46. Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome. Corrêa T; Mayndra M; Santos-Rebouças CB Mol Neurobiol; 2022 May; 59(5):3159-3169. PubMed ID: 35278209 [TBL] [Abstract][Full Text] [Related]
47. Pharmacology, efficacy, and tolerability of potassium bromide in childhood epilepsy. Korinthenberg R; Burkart P; Woelfle C; Moenting JS; Ernst JP J Child Neurol; 2007 Apr; 22(4):414-8. PubMed ID: 17621520 [TBL] [Abstract][Full Text] [Related]
48. A case for cannabidiol in Wolf-Hirschhorn syndrome seizure management. Ho KS; Wassman ER Am J Med Genet A; 2017 Feb; 173(2):324-326. PubMed ID: 28102593 [TBL] [Abstract][Full Text] [Related]
49. Unmasking of a hemizygous WFS1 gene mutation by a chromosome 4p deletion of 8.3 Mb in a patient with Wolf-Hirschhorn syndrome. Flipsen-ten Berg K; van Hasselt PM; Eleveld MJ; van der Wijst SE; Hol FA; de Vroede MA; Beemer FA; Hochstenbach PF; Poot M Eur J Hum Genet; 2007 Nov; 15(11):1132-8. PubMed ID: 17637805 [TBL] [Abstract][Full Text] [Related]
50. Severe congenital bilateral corneal ulceration due to Wolf-Hirschhorn syndrome: a case-report and review of the ophthalmic literature. King C; Mota PM; Hildebrand GD J AAPOS; 2019 Oct; 23(5):303-305. PubMed ID: 31513906 [TBL] [Abstract][Full Text] [Related]
51. [A case of peculiar type of post-encephalitic/encephalopathic epilepsy: efficacy of bromide in the control of intractable seizures]. Takusa Y; Hori D; Saito K; Kanai R; Sejima H; Kimura M; Kishi K; Yamaguchi S No To Hattatsu; 2001 Jul; 33(4):351-6. PubMed ID: 11494580 [TBL] [Abstract][Full Text] [Related]
52. Two successful cases of bromide therapy for refractory symptomatic localization-related epilepsy. Takayanagi M; Yamamoto K; Nakagawa H; Munakata M; Kato R; Yokoyama H; Haginoya K; Iinuma K Brain Dev; 2002 Apr; 24(3):194-6. PubMed ID: 11934520 [TBL] [Abstract][Full Text] [Related]
53. Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase. Ueda R; Saito Y; Ohno K; Maruta K; Matsunami K; Saiki Y; Sokota T; Sugihara S; Nishimura Y; Tamasaki A; Narita A; Imamura A; Maegaki Y Brain Dev; 2015 May; 37(5):471-7. PubMed ID: 25174548 [TBL] [Abstract][Full Text] [Related]
54. Clinical features in adult patient with Wolf-Hirschhorn syndrome. Martínez-Quintana E; Rodríguez-González F Morphologie; 2014 Jun; 98(321):86-9. PubMed ID: 24656633 [TBL] [Abstract][Full Text] [Related]
55. Electroclinical patterns and evolution of epilepsy in the 4p- syndrome. Battaglia D; Zampino G; Zollino M; Mariotti P; Acquafondata C; Lettori D; Pane M; Vasta I; Neri G; Dravet C; Guzzetta F Epilepsia; 2003 Sep; 44(9):1183-90. PubMed ID: 12919390 [TBL] [Abstract][Full Text] [Related]
56. [Clinical polymorphism of malignant epilepsy of infancy with migrating multifocal seizures (8 cases)]. Petrukhin AS; Kholin AA; Il'ina ES; Alikhanov AA; Voronkova KV; Lemeshko ID; Mukhin KIu Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 3():8-21. PubMed ID: 19621482 [TBL] [Abstract][Full Text] [Related]
57. Wolf-Hirschhorn Syndrome with Epibulbar Dermoid: An Unusual Association in a Patient with 4p Deletion and Functional Xp Disomy. Bragagnolo S; Colovati ME; Guilherme RS; Dantas AG; de Souza MZ; de Soares MF; Melaragno MI; Perez AB Cytogenet Genome Res; 2016; 150(1):17-22. PubMed ID: 27842301 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Trepanier LA; Van Schoick A; Schwark WS; Carrillo J J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942 [TBL] [Abstract][Full Text] [Related]
59. Clinical characterization and proposed mechanism of juvenile glaucoma--a patient with a chromosome 4p deletion, Wolf-Hirschhorn Syndrome. Curtin J; Moloney G; Grigg J; Sharota Franzco D Ophthalmic Genet; 2010 Sep; 31(3):135-8. PubMed ID: 20569021 [TBL] [Abstract][Full Text] [Related]
60. Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs. Gaskill CL; Cribb AE Can Vet J; 2000 Jul; 41(7):555-8. PubMed ID: 10907578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]